UPDATE: Baird Downgrades Vir Biotechnology (VIR) to Underperform
Tweet Send to a Friend
(Updated - December 21, 2021 6:20 AM EST)
Baird analyst Joel Beatty downgraded Vir Biotechnology (NASDAQ: VIR) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Baird analyst Joel Beatty downgraded Vir Biotechnology (NASDAQ: VIR) from Neutral ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
